India Leads In Anti-Cancer Medicine Manufacturing
India meets the global demand for anticancer medicines, with robust Research and Development facilities, developing new drug moieties, leading expertise, adapting the evolving regulatory standards.
With the State of Art Infrastructure
Indian companies contribute to investing in the latest drug development, developing formulations with a patient-centric approach to enhance efficacy and better safety.
Clinical Research
India conducts the majority of clinical trials for Novel Drug Discoveries.
- • India has a diverse genetic pool.
- • High-quality data collection and accountability.
- • Government supporting and funding pre-clinical and clinical research.
Government Approvals and Regulatory Support
Fast track government approvals, reduction in review time and waiver for local trials.
CDSCO provide provision for accelerated reviews for patented drugs, conditional approvals and relaxation for local trials.
Assured Quality and Safety
Strict Post market surveillance and pharmacovigilant standards for the manufacturing companies to address patient safety and therapeutic efficacy.
Globally Approved Manufacturing Capabilities
Facilities that meet the international regulatory standards and GMP practices.
High Demand for Indian Oncology Medicines?
Indian oncology products are in high demand due to:
Affordability
- • Low operational cost
- • low labor cost
- • Drug pricing controls by the national pharmaceutical pricing authority to meet the global demand.
Advanced Therapy
Indian companies invest in developing Novel drug therapies in oncology care:
- • Biosimilars
- • Patented biologics and antibody conjugates,
- • Drugs targeting genetic mutations,
- • Drugs modifying immune responses.
- • Targeted therapies
Global Partnerships and Collaborations
Indian pharmaceutical manufacturers actively collaborate with global pharmaceutical companies and develop strong distribution networks and facilitate research and drug development.
Export and Global Expansion
Penetrating the emerging markets, the Indian anticancer drugs has the widest rich:
- • Africa
- • South East Asia
- • CIS countries
- • South America
- • European countries
Aprazer Healthcare –Top Oncology Drug Exporters and Manufacturers from India
Develops the widest range of anticancer drugs focused on new drug development:
- • Chemotherapy drugs
- • Targeted therapies
- • Immunotherapy
- • Hormone therapy
Global Reach
Present across more than 50 countries across the globe, we have strong footprints in Africa, South America, Southeast Asia, and CIS countries.
Adherence to International Standards
WHO-GMP, EU-GMP certified facilities and strict adherence to the evolving regulatory standards.
Competitive Pricing and Consistent Quality
Streamlined manufacturing process, continuous production, minimizing wastage, implementing the cutting-edge technology, we assure the best quality and potent therapeutic efficacy.
Collaborations and Partnerships
Committed to affordable patient care, we have extensive partnerships in hospitals, government healthcare programs, dispensaries, healthcare centers, clinics and healthcare professionals.
Partnerships with more than 150 clients across the globe, we collaborate with the global pharmaceutical innovators and investors, cross-selling our products across the world markets.
